About: The Impact of RSV-Associated Respiratory Disease on Children in Asia

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: The Impact of RSV-Associated Respiratory Disease on Children in Asia Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	The Impact of RSV-Associated Respiratory Disease on Children in Asia
Creator	Noordeen, Faseeha Ahamed, Rukshan Divarathne, Manike Vyanga, Maduja
Source	Medline; PMC
abstract	Acute respiratory tract infections (ARTIs) are leading contributors to the global infectious disease burden, which is estimated to be 112,900,000 disability adjusted life years. Viruses contribute to the etiology of ARTIs in a big way compared with other microorganisms. Since the discovery of respiratory syncytial virus (RSV) 61 years ago, the virus has been recognized as a major cause of ARTI and hospitalization in children. The morbidity and mortality attributable to RSV infection appear to be higher in infants < 3 months and in those with known risk factors such as prematurity, chronic lung, and congenital heart diseases. Crowded living conditions, exposure to tobacco smoke, and industrial or other types of air pollution also increase the risk of RSV-associated ARTI. Many epidemiological studies have been conducted in developed countries to understand the seasonal patterns and risk factors associated with RSV infections. Dearth of information on RSV-associated morbidity and mortality in Asian and developing countries indicates the need for regional reviews to evaluate RSV-associated disease burden in these countries. Epidemiological studies including surveillance is the key to track the disease burden including risk factors, seasonality, morbidity, and mortality associated with RSV infection in these countries. These data will contribute to improve the clinical diagnosis and plan preventive strategies in resource-limited developing countries.
has issue date	2018-04-11(xsd:dateTime)
bibo:doi	10.1055/s-0038-1637752
bibo:pmid	32300274
has license	no-cc
sha1sum (hex)	f9e8403016965e4c7e7e3265cef147658a3e2668
schema:url	https://doi.org/10.1055/s-0038-1637752
resource representing a document's title	The Impact of RSV-Associated Respiratory Disease on Children in Asia
has PubMed Central identifier	PMC7117084
has PubMed identifier	32300274
schema:publication	J Pediatr Infect Dis
resource representing a document's body	covid:f9e8403016965e4c7e7e3265cef147658a3e2668#body_text
is schema:about of	named entity 'Impact' named entity 'sub-Saharan Africa' named entity 'RSV' named entity 'RSV' named entity 'epidemiological' named entity 'RSV' named entity 'Alaska' named entity 'United States' named entity 'conserved region' named entity 'monoclonal antibody' named entity 'bronchitis' named entity 'United Kingdom' named entity 'chest X-rays' named entity 'respiratory syncytial virus' named entity 'influenza' named entity 'Asia' named entity 'compromised immunity' named entity 'developing countries' named entity 'stop codon' named entity 'physiology' named entity 'health care systems' named entity 'infection' named entity 'RSV' named entity 'RSV' named entity 'immunogenicity' named entity 'RSV' named entity 'viruses' named entity 'inflammation' named entity 'LRTI' named entity 'bronchiolitis' named entity 'neutralizing antibodies' named entity 'RSV' named entity 'positive selection' named entity 'congenital heart disease' named entity 'mucolytic' named entity 'prophylactic treatment' named entity 'Hong Kong' named entity 'asthma' named entity 'epidemics' named entity 'epithelial cells' named entity 'collection of fluid' named entity 'RSV' named entity 'atopy' named entity 'genotype' named entity 'RSV' named entity 'United States' named entity 'immunogenicity' named entity 'humoral' named entity 'risk factors' named entity 'RSV' named entity 'wheezes' named entity 'China' named entity 'bacteria' named entity 'recombinant' named entity 'RSV' named entity 'RSV' named entity 'antibodies' named entity 'WHO' named entity 'RSV' named entity 'virus' named entity 'coryza' named entity 'community-acquired' named entity 'RSV infection' named entity 'temperate regions' named entity 'vaccine' named entity 'RSV' named entity 'RSV' named entity 'RSV' named entity 'RSV' named entity 'risk factors' named entity 'mAb' named entity 'Yukon-Kuskokwim Delta' named entity 'RSV' named entity 'prematurity' named entity 'lower respiratory tract' named entity 'RSV' named entity 'nucleic acid' named entity 'wheeze'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software